Actualités Diagnos Inc - ADK | Actions TSX Venture Exchange

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

DIAGNOS Announces Shares for Debt Settlement

BROSSARD, Quebec, June 18, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform

BROSSARD, Quebec, June 16, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting

BROSSARD, Quebec, June 12, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Announces Amendment to Convertible Debentures

BROSSARD, Quebec, May 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA

BROSSARD, Quebec, April 08, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration

BROSSARD, Quebec, April 01, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Announces Amendments to Convertible Debentures and Stock Warrants

BROSSARD, Quebec, March 05, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference

BROSSARD, Quebec, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation

BROSSARD, Quebec, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Announces the Engagement of IBN

BROSSARD, Quebec, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Advances Regulatory Strategy for CARA in Key Markets: Updates on Health Canada, FDA, and SFDA Progress

BROSSARD, Quebec, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence (AI) Scientist to Accelerate our Innovation in Healthcare

BROSSARD, Quebec, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Diagnos Inc (ADK)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Diagnos Inc (ADK) Actualités

DIAGNOS Announces Shares for Debt Settlement

DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform

DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting

DIAGNOS Announces Amendment to Convertible Debentures

DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA

DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration

DIAGNOS Announces Amendments to Convertible Debentures and Stock Warrants

DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference

DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation

DIAGNOS Announces the Engagement of IBN

DIAGNOS Advances Regulatory Strategy for CARA in Key Markets: Updates on Health Canada, FDA, and SFDA Progress

DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence (AI) Scientist to Accelerate our Innovation in Healthcare

Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital

Diagnos Announces Upsize of Previously Announced Brokered Private Placement to $3.65M Led by Centurion One Capital

DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

Diagnos Inc (ADK)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Diagnos Inc (ADK) Actualités

DIAGNOS Announces Shares for Debt Settlement

DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform

DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting

DIAGNOS Announces Amendment to Convertible Debentures

DIAGNOS Provides an Update on Sales and Regulatory Activities for CARA

DIAGNOS Successfully Completes the Renewal of US-FDA Medical Device Establishment Registration

DIAGNOS Announces Amendments to Convertible Debentures and Stock Warrants

DIAGNOS to present at Centurion One Capital 9th Annual Toronto Growth Conference

DIAGNOS and ÉTS Announce $1M+ Federal Investment to Propel Next-Generation Retinal AI Innovation

DIAGNOS Announces the Engagement of IBN

DIAGNOS Advances Regulatory Strategy for CARA in Key Markets: Updates on Health Canada, FDA, and SFDA Progress

DIAGNOS Appoints Dr. Ismail Ben Ayed as Chief Artificial Intelligence (AI) Scientist to Accelerate our Innovation in Healthcare

Diagnos Announces Closing of Oversubscribed $4 Million Brokered Private Placement Led by Centurion One Capital

Diagnos Announces Upsize of Previously Announced Brokered Private Placement to $3.65M Led by Centurion One Capital

DIAGNOS to Extend Exercise Period of Stock Warrants Expiring on December 5, 2025

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Sign up for FREE and get:

Supprimer les publicités